The Endoscopy Division of Smith & Nephew said that its TRUCLEAR System, an operative hysteroscopy device for the removal of intrauterine polyps and fibroids, has surpassed the 30,000 procedure milestone.
The TRUCLEAR System pairs the visualization capabilities of a hysteroscope with minimally invasive tissue removal capabilities from the uterine cavity and allows healthcare practitioners in obstetrics, gynecology and reproductive health to capture and remove intrauterine polyps and fibroids.
Smith & Nephew Endoscopy Gynecology GM Mira Sahney said the system is optimized to thoroughly and efficiently remove tissue so that physicians are not required to make multiple, time-consuming insertions into the uterine cavity and this helps to reduce the risk of damage, which may also help preserve the chances of a future pregnancy.
Smith & Nephew has a patent infringement lawsuit pending in the US District Court in Massachusetts against Hologic, claiming their MyoSure Tissue Removal System infringes a patent specifically used for the TRUCLEAR System and for minimally invasive treatment of intrauterine polyps and fibroids.
The lawsuit was initially filed against Interlace Medical which was subsequently acquired by Hologic in January 2011.